π Pharmidex Clinical Pathology Services – Advancing Drug Development! π
February 3, 2025
We’re excited to offer Clinical Chemistry Services to support drug development and research. Our Siemens analyser delivers precise, high-throughput results across key biological parameters.
π¬ Our Expertise Covers:
β Liver & Kidney Function
β Protein & Energy Metabolism
β Electrolytes & Minerals
π‘Supporting human & animal models.
π¦ Sample Details:
Minimum 30 µL (+50 µL dead volume)
Heparin plasma, serum, urine
Whether assessing drug safety or metabolic responses, we provide accurate, reliable data to accelerate your research.
π© Get in touch to learn how we can support your studies!ο»Ώ
#Pharmidex #ClinicalPathology #ClinicalChemistry #DrugDevelopment #Innovation
Pharmidex team are delighted to participate in workshop on "Re-shaping UK life science commercialisation strategy" organised by The Research and Development Society on Wednesday 11th June, at Mereside, Alderley Park. If you are attending, please linkup with our colleague Mo Alavijeh who will be delighted to meet you. Jamie Phadke , Alderley Park #UKlifescience https://lnkd.in/e6uKsRcN
Martin Barrett , Head of Business Development, will attend the symposium on 10–13 June 2025 at Hotel Comwell Borupgaard, Denmark. The event gathers top European scientists to discuss drug discovery. Martin looks forward to connecting with academia, CROs, and pharma to explore collaborations and showcase Pharmidex’s services from in silico to in vivo pharmacology. Attending? Let’s connect! π https://lnkd.in/ev7TW7WG
We’re excited to announce our involvement in the recent publication: "Anti-Inflammatory Activity of Ensifentrine: A Novel, Selective Dual Inhibitor of PDE3 and PDE4" π https://pubmed.ncbi.nlm.nih.gov/40245851/ π https://www.pharmidex.com/publications-by-pharmidex Dr. Radhakrishnan Venkatasamy , our Senior Scientist in autoinflammatory and immune diseases, co-authored this study highlighting Ensifentrine’s anti-inflammatory potential. This reflects Pharmidex’s commitment to advancing therapies through expert science and collaboration.
